How Aethlon Medical ($AEMD) is Looking to Tackle Bird Flu

Поділитися
Вставка
  • Опубліковано 11 лют 2025
  • Aethlon Medical's (AEMD) Hemopurifier, an FDA-designated Breakthrough Device, targets cancer, viral infections, and organ transplantation. It does so by removing harmful extracellular vesicles and life threatening viruses using proprietary lectin-based technology. We’ll be diving into its latest update.
    Learn more here: www.aethlonmed...
    Follow me on Stocktwits: stocktwits.com...
    Business Inquiries: Media@undervaluedinvestor.com
    __________________________________________________________________________________
    My UA-cam videos are for informational purposes only and not financial advice. I'm not a licensed financial professional, and nothing here is a recommendation to buy or sell any asset. Consult your financial advisor, and do your own research to take full responsibility for your decisions. I'm not liable for any losses.
    This distribution was conducted on behalf of Aethlon Medical, Inc.(NASDAQ: AEMD). and was funded by Outside The Box Capital Inc. and/or affiliates after Undervalued Investor was engaged by Outside The Box Capital Inc. to advertise for Aethlon Medical, Inc.(NASDAQ: AEMD).
    For our full disclaimer, please visit:
    bit.ly/405PAD5

КОМЕНТАРІ • 10